Akebia Therapeutics Inc
SWB:AX9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Akebia Therapeutics Inc
SWB:AX9
|
US |
|
COSCO Shipping Holdings Co Ltd
OTC:CICOF
|
CN |
|
T
|
Tegna Inc
SWB:GTT
|
US |
|
Elite Material Co Ltd
TWSE:2383
|
TW |
|
B
|
BCE Inc
SWB:BCE1
|
CA |
|
V
|
Vodafone Group PLC
XMUN:VODI
|
UK |
|
T
|
Tenable Holdings Inc
SWB:TE7
|
US |
|
U
|
United Parcel Service Inc
XMUN:UPAB
|
US |
|
Colliers International Group Inc
TSX:CIGI
|
CA |
|
N
|
National Grid PLC
F:NNGD
|
UK |
|
Amadeus IT Group SA
F:AI3A
|
ES |
|
Severn Trent PLC
LSE:SVT
|
UK |
|
M
|
Masco Corp
BMV:MAS
|
US |
|
B
|
Bitdeer Technologies Group
NASDAQ:BTDR
|
SG |
|
S
|
Sinopharm Group Co Ltd
F:X2S
|
CN |
|
S
|
SoftBank Corp
SWB:3AG1
|
JP |
|
Arrow Electronics Inc
NYSE:ARW
|
US |
|
I
|
IPD Group Ltd
ASX:IPG
|
AU |
|
A
|
Atoss Software AG
XHAM:AOF
|
DE |
|
Hanjaya Mandala Sampoerna Tbk PT
OTC:PHJMF
|
ID |
|
Ventas Inc
NYSE:VTR
|
US |
|
N
|
Natera Inc
F:45E
|
US |
|
Canada Goose Holdings Inc
LSE:0UNA
|
CA |
|
E
|
Essex Property Trust Inc
F:EXP
|
US |
Bankruptcy Probability
Akebia Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Akebia Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Akebia Therapeutics Inc
NASDAQ:AKBA
|
243.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
466.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
205.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
187.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
63.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84.1B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
52.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Akebia Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Akebia Therapeutics Inc has total debt of 156.9m USD. This includes both short-term (0 USD) and long-term (156.9m USD) debt.
You can find a full breakdown on its Balance Sheet.